Skip to content
10-Q

Quarterly Report

BIOPLUS LIFE CORP

0001493152-19-012302

← back to feed
Filed
Aug 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 14, 2019 359.31M sh
Cash And Equivalents Q2 2019 · Jun 30, 2019 $158.71K
Cash And Equivalents Q2 2019 · Dec 31, 2018 $398.13K
Stockholders Equity Q2 2019 · Jun 30, 2019 $1.76M
Stockholders Equity Q2 2019 · Dec 31, 2018 $1.8M
Stockholders Equity Q2 2019 · Dec 31, 2017 $1.83M
Current Liabilities Q2 2019 · Jun 30, 2019 $491.7K
Current Liabilities Q2 2019 · Dec 31, 2018 $976.35K
Total Liabilities Q2 2019 · Jun 30, 2019 $1.19M
Total Liabilities Q2 2019 · Dec 31, 2018 $1.67M
Current Assets Q2 2019 · Jun 30, 2019 $806.15K
Current Assets Q2 2019 · Dec 31, 2018 $1.28M
Total Assets Q2 2019 · Jun 30, 2019 $2.95M
Total Assets Q2 2019 · Dec 31, 2018 $3.47M
Net Income Q2 2019 · Dec 31, 2018 −$110.34K
Net Income Q2 2019 · Jun 30, 2018 $78.36K
Net Income Q2 2019 · Jun 30, 2018 −$1.53K
Capex Q2 2019 · Jun 30, 2018 $144.92K
Operating Cash Flow Q2 2019 · Jun 30, 2018 $284.96K
Sga Expense Q2 2019 · Jun 30, 2018 $295.37K
Sga Expense Q2 2019 · Jun 30, 2018 $500.35K
Operating Income Q2 2019 · Jun 30, 2018 $78.36K
Operating Income Q2 2019 · Jun 30, 2018 −$1.53K
Gross Profit Q2 2019 · Jun 30, 2018 $381.4K
Gross Profit Q2 2019 · Jun 30, 2018 $522.4K
Cost Of Revenue Q2 2019 · Jun 30, 2018 $500.63K
Cost Of Revenue Q2 2019 · Jun 30, 2018 $738.14K
Revenue Q2 2019 · Jun 30, 2018 $882.03K
Revenue Q2 2019 · Jun 30, 2018 $1.26M